Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Return on Capital Employed (2020 - 2025)

Benitec Biopharma (BNTC) has disclosed Return on Capital Employed for 6 consecutive years, with 0.22% as the latest value for Q1 2025.

  • Quarterly Return on Capital Employed rose 124.0% to 0.22% in Q1 2025 from the year-ago period, while the trailing twelve-month figure was 0.22% through Mar 2025, up 124.0% year-over-year, with the annual reading at 0.96% for FY2024, 1442.0% up from the prior year.
  • Return on Capital Employed hit 0.22% in Q1 2025 for Benitec Biopharma, up from 0.25% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.22% in Q1 2025 to a low of 8.07% in Q2 2023.
  • Historically, Return on Capital Employed has averaged 1.73% across 5 years, with a median of 1.29% in 2021.
  • Biggest five-year swings in Return on Capital Employed: plummeted -482bps in 2023 and later skyrocketed 729bps in 2024.
  • Year by year, Return on Capital Employed stood at 1.29% in 2021, then decreased by -14bps to 1.47% in 2022, then rose by 20bps to 1.18% in 2023, then surged by 79bps to 0.25% in 2024, then grew by 12bps to 0.22% in 2025.
  • Business Quant data shows Return on Capital Employed for BNTC at 0.22% in Q1 2025, 0.25% in Q4 2024, and 0.4% in Q3 2024.